跳至主要内容
临床试验/NCT06838507
NCT06838507尚未招募不适用

Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated Ketoacidosis - a Multicentre Prospective Cohort Study

Heinrich-Heine University, Duesseldorf1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2025年4月最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
2,000
试验地点
1
主要终点
Number of patients with postoperative ketoacidosis

研究概览

简要总结

The goal of this observational study is to generate data on the incidence and outcome-relevance of sodium-glucose cotransporter 2 (SGLT2) inhibitor associated ketoacidosis in adult patients with regular intake of any SGLT2 inhibitor within the last three months that are undergoing in-patient surgery. Further, it will describe strategies in current clinical practice to prevent and manage SGLT2 inhibitor associated ketoacidosis. The specific aims of this study are:

  1. To assess the incidence of SGLT2 inhibitor associated ketoacidosis in surgical patients
  2. To characterise fasting times in patients with SGLT2 inhibitor associated ketoacidosis
  3. To describe the management of SGLT2 inhibitor associated ketoacidosis in current clinical practice
  4. To assess the outcome impact of SGLT2 inhibitor associated ketoacidosis

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Prescription and regular intakte of any SGLT2 inhibitor within the last three months (regardless if SGLT2 inhibitor was discontinued preoperatively or not)
  • Surgical procedure
  • At least one overnight stay in the hospital following surgery
  • Age >= 18 years

排除标准

  • Unwilling and/or unable to consent
  • Outpatient surgery

结局指标

主要结局

Number of patients with postoperative ketoacidosis

时间窗: From the immediate postoperative period to the first postoperative morning

Ketoacidosis will be defined as by the American Diabetes Association: * pH \<= 7,30 * Serum bicarbonate \<= 18 mmol/l * Serum and/or urine ketones positive

次要结局

  • Composite of postoperative complications(From enrollment to the end of follow up at 30 days after discharge)
  • Single postoperative complication(From enrollment to the end of follow up at 30 days after discharge)
  • Acute kidney injury(From enrollment to the end of follow up at 30 days after discharge)
  • Length of stay in-hospital(From enrollment to discharge (in-hospital) at approximately four days after surgery)
  • Length of stay on intensive care unit(From entering the intensive care unit to discharge to the normal ward at approximately 2 days after surgery)
  • Length of stay in the recovery room(From entering the recovery room to discharge to the normal ward at approximately one hour after surgery)

研究者

发起方
Heinrich-Heine University, Duesseldorf
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验